Explaining fatigue in congestive heart failure

Annual Review of Medicine

Volumn 47, Issue , 1996, Pages 241-256

  Drexler, Helmut ^a   Coats, Andrew J S ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Exercise capacity; Muscle strength and endurance; Peripheral perfusion; Skeletal muscle

Indexed keywords

BLOOD FLOW; CONGESTIVE HEART FAILURE; EXERCISE; FATIGUE; HEART OUTPUT; HUMAN; METABOLISM; MUSCLE BLOOD FLOW; OXYGEN TRANSPORT; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; TRAINING;

ACTIVITIES OF DAILY LIVING; EXERCISE TEST; FATIGUE; GENERAL ADAPTATION SYNDROME; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; MUSCLE CONTRACTION; MUSCLE, SKELETAL; QUALITY OF LIFE; REGIONAL BLOOD FLOW;

EID: 0029942817     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.47.1.241     Document Type: Review

References (83)

1. Lipkin DP, Canepa-Anson R, Stephens MR, et al. 1986. Factors determining symptoms in heart failure: comparison of fast and slow exercise tests. Br. Heart J. 55: 439-45
2. Clark AL, Sparrow JL, Coats AJS. 1995. Muscle fatigue and dyspnoea in chronic heart failure: two sides of the same coin? Eur. Heart J. 16:49-52
3. Poole-Wilson PA. 1989. Chronic heart failure: causes, pathophysiology, prognosis, clinical manifestations, investigations. In Diseases of the Heart, ed. PA Poole-Wilson, pp. 48-57 London: Balliere Tindall
4. Sparrow J, Parameshwar J, Poole-Wilson PA, et al. 1994. Assessment of functional capacity in chronic heart failure: time-limited exercise on a self-powered treadmill. Br. Heart J. 71:391-94
5. Borg GA. 1975. Perceived exertion: a note on history and methods. Med. Sci. Sports Exerc. 5:90-93
6. Wilson JR, Martin JL, Schwartz D, et al. 1984. Exercise intolerance in patients with chronic heart failure: role of impaired nutrilive flow to skeletal muscle. Circulation 69:1079-87
7. Mancini DM, Schwartz M, Ferraro N, et al. 1990. Effect of dobutamine on skeletal muscle metabolism in patients with congestive heart failure. Am. J. Cardiol. 65: 1121-26
8. Herrlin B, Nyquist O, Sylen C. 1991. Induction of a reduction in haemoglobin concentration by enalapril in stable, moderate heart failure: a double blind study. Br. Heart J. 66:199-205
9. Moore DP, Weston AR, Hughes JM, et al. 1992. Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure [letter]. Lancet 339: 850-53
10. Clark AL, Coats AJ. 1992. Increased oxygen and exercise performance in chronic heart failure [letter]. Lancet 340:184-85
11. Mancini DM, Wilson JR, Bolinger L, et al. 1994. In vivo magnetic resonance spectroscopy measurement of deoxymyoglobin during exercise in patients with heart failure. Circulation 90:500-8
12. Zelis R, Longhurst J, Capone RJ, et al. 1974. A comparison of regional blood flow and oxygen utilization during dynamic forearm exercise in normal subjects and patients with congestive heart failure. Circulation 50:137-43
13. Drexler H, Faude F, Höing S, et al. 1987. Blood flow distribution within skeletal muscle during exercise in the presence of chronic heart failure: effect of milrinone. Circulation 76:1344-52
14. Drexler H, Banhardt U, Meinertz T, et al. 1989. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial. Circulation 79:491-502
15. Sullivan MJ, Knight JD, Higginbotham MB, et al. 1989. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Circulation 80:769-81
16. LeJemtel TH, Maskin CS, Lucido D, et al. 1986. Failure to augment maximal limb blood flow in response to one leg versus two-leg exercise in patients with severe heart failure. Circulation 74:245-51
17. McMurray JJ, Ray SG, Abdullah I, et al. 1992. Plasma endothelin in chronic heart failure. Circulation 85:1374-79
18. Giaid A, Yanagisawa M, Langleben D, et al. 1993. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 328:1732-39
19. Kiowski W, Bertel O, Sütsch G, et al. 1995. Vasodilator effects of the endothelin-1 receptor antagonist bosentan in patients with severe chronic heart failure. J Am. Coll. Cardiol. 25:296A (Abstr.)
20. Zelis R, Mason DT, Braunwald E. 1968. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and patients with congestive heart failure. J. Clin. Invest. 47:960-70
21. Wilson JR, Ferraro N. 1985. Effect of renin-angiotensin system on limb circulation and metabolism during exercise in patients with heart failure. J. Am. Coll. Cardiol. 6:556-63
22. Jeserich M, Pape L, Just H, et al. 1995. Effect of longterm ACE inhibition on vascular function in patients with chronic heart failure. Am. J. Cardiol. 26:50-56
23. Captopril Multicenter Research Group. 1983. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. J. Am. Coll. Cardiol. 2:755-63
24. Geisterfer AAT, Peach MJ, Owens GK. 1988. Angiotensin II induces hypertrophy not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62:749-56
25. Schieffer B, Wollert K, Berchthold M, et al. 1995. Development and prevention of skeletal muscle structural alterations after experimental myocardial infarction. Am. J. Physiol. In press
26. Sinoway LI, Minotti J, Musch T, et al. 1987. Enhanced metabolic vasodilation secondary to diuretic therapy in decompensated congestive heart failure secondary to coronary artery disease. Am. J. Cardiol. 60: 107-11
27. Drexler H, Lu W. 1992. Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure. Am. J. Physiol. 262:H1640-45
28. Drexler H, Hayoz D, Münzel T, et al. 1992. Endothelial function in chronic congestive heart failure. Am. J. Cardiol. 69:1596-601
29. Kubo SH, Rector TS, Bank AJ, et al. 1991. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 84:1589-96
30. Tagawa T, Imaizumi T, Endo T, et al. 1994. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation 90: 2285-90
31. Loscalzo J, Vita JA. 1994. Ischemia, hyperemia, exercise, and nitric oxide: complex physiology and complex molecular adaptations. Circulation 90:2556-59
32. Gilligan DM, Panza JA, Kilcoyne CM, et al. 1994. The contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation 90:2853-58
33. Wilson JR, Kapoor S. 1993. Contribution of endothelium-derived relaxing factor to exercise-induced vasodilation in humans. J. Appl. Physiol. 75:2740-44
34. Hirooka Y, Imaizumi T, Tagawa T, et al. 1994. Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation 90:658-68
35. Wilson JR, Mancini DM, Dunkman WB. 1993. Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation 87:470-75
36. Zelis R, Nellis SH, Longhurst J, et al. 1975. Abnormalities in the regional circulations accompanying congestive heart failure. Progr. Cardiovasc. Dis. 18:181-89
37. Kobzik L, Reid MB, Bredt DS, et al. 1994. Nitric oxide in skeletal muscle. Nature 372: 546-48
38. Wilson JR, Martin JL, Ferraro N, et al. 1983. Effect of hydralazine on perfusion and metabolism in the leg during up-right bicycle exercise in patients with heart failure. Circulation 68:425-32
39. Rowell LB. 1974. Human cardiovascular adjustments to exercise and thermal stress. Physiol. Rev. 54:75-159
40. Jondeau G, Katz SD, Zohman L, et al. 1992. Active skeletal muscle mass and cardiopulmonary reserve: failure to attain peak aerobic capacity during maximal bicycle exercise in patients with severe congestive heart failure. Circulation 86: 1351-56
41. Mancini DM, Walter G, Reichek N, et al. 1992. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85:1364-73
42. Lipkin DP, Jones DA, Round JM, et al. 1988. Abnormalities of skeletal muscle in patients with chronic heart failure. Int. J. Cardiol. 18:187-95
43. Drexler H, Riede U, Münzel T, et al. 1992. Alterations of skeletal muscle in chronic heart failure. Circulation 85:1751-59
44. Sullivan MJ, Green HJ, Cobb FR. 1990. Skeletal muscle biochemistry and histology in ambulatory patients with longterm heart failure. Circulation 81:518-27
45. Drexler H. 1992. The effect of ACE-innibitors on the peripheral circulation in heart failure. Am. J. Cardiol. 70:50C-54C
46. Drexler H. 1992. Skeletal muscle failure in heart failure. Circulation 85:1621-23
47. Wilson JR, Fink L, Maris J, et al. 1985. Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. Circulation 71:57-62
48. Massie BM, Conway M, Yonge R, et al. 1987. 31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure. Am. J. Cardiol. 60:309-15
49. Victor RG, Bertocci LA, Pryor SL, et al. 1988. Sympathetic nerve discharge is coupled to muscle cell pH during exercise in man. J Clin. Invest. 82:1301-5
50. Goldsmith SR, Iber C, McArthur CD, et al. 1990. Influence of acid-base status on plasma catecholamines during exercise in normal humans. Am. J. Physiol. 258: R1411-16
51. Mancini DM, Walter G, Reichek N, et al. 1992. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85:1364-73
52. Minotti JR, Christoph I, Oka R, et al. 1991. Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance. J. Clin. Invest. 88:2077-82
53. Minotti JR, Pillay P, Change L, et al. 1992. Neurophysiological assessment of skeletal muscle fatigue in patients with congestive heart failure. Circulation 86:903-8
54. Buller NP, Jones D, Poole-Wilson PA. 1991. Direct measurements of skeletal muscle fatigue in patients with chronic heart failure. Br. Heart J. 65:20-24
55. Mancini DM, Henson D, LaManca J, et al. 1994. Evidence of reduced respiratory muscle endurance in patients with heart failure. J. Am. Coll. Cardiol. 24:972-81
56. Mancini DM, Ferraro N, Nazzaro D, et al. 1991. Respiratory muscle deoxygenation during exercise in patients with heart failure demonstrated with near-infrared spectroscopy. J Am. Coll. Cardiol. 18:492-98
57. Lindsay DC, Lovegrove C, Dunn MJ, et al. 1993. Histological abnormalities of limb and respiratory muscles in heart failure. Circulation 88(Suppl. I):414 (Abstr.)
58. Mancini DM, Henson D, LaManca J, et al. 1992. Respiratory muscle function and dyspnea in patients with chronic congestive heart failure. Circulation 86:909-19
59. Brunotte F, Thompson CH, Adamopoulos S, et al. 1995. Rat skeletal muscle metabolism in experimental heart failure: effects of physical training. Acta Physiol. Scand. In press
60. Sullivan MJ, Higginbotham MB, Cobb FR. 1988. Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects. Circulation 78:506-15
61. Adamopolous S, Coats AJS, Brunotte F, et al. 1993. Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J. Am. Coll. Cardiol. 21:1101-6
62. Hambrecht R, Niebauer J, Fiehn E, et al. 1995. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J. Am. Coll. Cardiol. 25:1239-49
63. Minotti JR, Johnson EC, Hudson TL, et al. 1990. Skeletal muscle response to exercise training in congestive heart failure. J. Clin. Invest. 86:751-58
64. Swan JW, Walton C, Godsland IF, et al. 1994. Insulin resistance in chronic heart failure. Eur. Heart J. 15:1528-32
65. Belch JJF, Bridges AB, Scott N, et al. 1991. Oxygen free radicals and congestive heart failure. Br. Heart J. 65:245-48
66. Kalman J, Levine B, Mayer L, et al. 1990. Prognostic importance of circulating neopterin in heart failure: evidence for monocyte activation in patients with cardiac cachexia. Circulation 82(Suppl. III):315
67. Levine B, Kalman J, Mayer L, et al. 1990. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323:236-41
68. Aoki N, Siegfried M, Lefer AM. 1989. Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries. Am. J. Physiol. 256:H1509-12
69. Warren RS, Starnes HF Jr, Gabrilove JL, et al. 1987. The acute metabolic effects of tumor necrosis factor administration in humans. Arch. Surg. 122:1396-400
70. Morrison WL, Gibson JN, Rennie MJ. 1988. Skeletal muscle and whole body protein turnover in cardiac cachexia: influence of branched-chain amino acid administration. Eur. J. Clin. Invest. 18:648-54
71. Dunnigan A, Staley NA, Smith SA, et al. 1987. Cardiac and skeletal muscle abnormalities in cardiomyopathy: comparison of patients with ventricular tachycardia or congestive heart failure. J. Am. Coll. Cardiol. 10:608-18
72. Caforio ALP, Rossi B, Risalti R, et al. 1989. Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: evidence of subclinical myogenic myopathy. J. Am. Coll. Cardiol. 14:1464-73
73. Wiener DH, Fink LI, Maris J, et al. 1986. Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. Circulation 73:1127-36
74. Massie BM, Conway M, Rajagopulan B, et al. 1988. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. Circulation 78:320-26
75. Coats AKS, Adamopoulos S, Meyer TE, et al. 1990. Effects of physical training in chronic heart failure. Lancet 335:63-66
76. Coats AJS, Adamopoulos S, Radaelli A, et al. 1992. Controlled trial of physical training in chronic heart failure: exercise performance, hemodynamics, ventilation and autonomic function. Circulation 85: 2119-31
77. Hornig B, Maier V, Drexler H. 1995. Physical training improves endothelial function in patients with chronic heart failure. Circulation. In press
78. Koch M, Douard H, Braustet JP. 1992. The benefit of graded physical exercise in chronic heart failure. Chest 101:231S-5S
79. Davey P, Meyer T, Coats A, et al. 1992. Ventilation in chronic heart failure: effects of physical training. Br. Heart J. 68:473-77
80. Drexler H, Kurz S, Jeserich M, et al. 1995. Effect of chronic angiotensin-converting-enzyme inhibition on endothelial function in patients with chronic heart failure. Am. Heart J. In press
81. Wiemer G, Schölkens BA, Becker RHA, et al. 1991. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 18:558-63
82. Mombouli J-V, Naphtali M, Vanhoutte PM. 1991. Effects of the converting enzyme inhibitor cilazaprilat on endothelium-dependent responses. Hypertension 18 (Suppl. II):22-29
83. Piepoli M, Clark AL, Volterrani M, et al. 1995. Contribution of muscle afferents to the hemodynamic, autonomic and ventilatory responses to exercise in patients with chronic heart failure. Effects of physical training. Circulation. In press